Merchient’s ingredient library
The library gives no supported wording for Bacillus coagulans, because no listed source supports one at a dose. Avoid wording that names or implies a disease, a drug or a treatment, such as “Relieves IBS or IBS symptoms”.
Also called: Weizmannia coagulans, Heyndrickxia coagulans, Lactobacillus sporogenes
Reviewed
Not legal advice. This guide shows the wording that published evidence supports at a daily dose; it is not a ruling on any claim. Your own product, its form and dose, and your own evidence still need to match the wording you use.
Supported wordings
Claims Facts
No supported wording yet.
No listed source gives a use with a dose for Bacillus coagulans. Health Canada’s probiotics monograph (dated 24 April 2026) excludes it, with Bacillus clausii, Bacillus indicus and Bacillus subtilis, in Appendix I, Table 6 (‘Excluded live microorganisms from this monograph’), so none of its uses or doses apply, and no other Health Canada monograph for it is in the monograph list. FDA lists no health claim, and Regulation (EU) No 432/2012 has none.
Wordings to avoid
Claims Facts
| Wording to avoid | Reason |
|---|---|
| “Relieves IBS or IBS symptoms”Names a disease. | Disease |
| “Stops diarrhea, or treats gut infections”Diarrhea and infections are disease states; no listed source supports it. | Disease |
| “Relieves constipation, without ‘occasional’”FDA’s 2000 rule (page 1015) accepts only the ‘occasional constipation’ form. | Treatment |
Disease: names or implies a disease. Drug: names a drug or presents the product as one. Treatment: promises to treat, cure or prevent a condition.
Sources
This guide cites no source yet; “What you can say” above explains why.
Vera, Merchient’s AI employee, reads your site and emails you the riskiest line, why, a safer rewrite and how many more like it she found. Reply, and you get the free first report.
Or write to hello@merchient.com